With Elizabeth Gluck, Christina Markus, Patrick Morrisey, Josh O'Hara, Preeya Pinto
This roadmap suggests next steps for pharmaceutical and biologics manufacturers to consider as they digest the ACA Proposed Rule and identify implications that merit comment.